Latest Announcements

Morepen Laboratories Ltd has released its Q1 FY 27 Investor Presentation, highlighting a 34% YoY increase in revenue, 207% YoY increase in EBITDA, and 394% YoY increase in PAT. The company attributes this performance to operational execution and commercial validation of its Morepen 2.0 strategy.

Dr. Agarwal's Health Care Ltd has announced its unaudited consolidated financial results for Q1 FY2027, with revenue from operations growing by 26.0% YoY to ₹614 Crores, and PAT growing by 44.6% YoY to ₹55 Crores. The company has also announced the appointment of new auditors, internal auditors, and cost auditors, and the incorporation of a wholly owned subsidiary in Nigeria.

Indian Metals & Ferro Alloys Ltd (IMFA) has announced its Q1 FY2027 earnings, reporting a record revenue of ₹960.45 crore, up 50% from ₹641.54 crore in Q1 FY26, driven by higher ferro chrome output and firm prices. The company's EBITDA and PAT also saw significant increases, to ₹281.27 crore and ₹191.49 crore, respectively. IMFA's Greenfield Expansion Project at Kalinganagar (KNR 1) is on track, with the first furnace expected to be commissioned in August 2026 and the second furnace in September 2026. The company has also signed a long-term offtake arrangement with Enfinity Global for an additional 65 MWp hybrid renewable energy, which will contribute to its green footprint.

Capillary Technologies India Limited has announced its financial results for the first quarter ended June 30, 2026, with a 43% year-on-year growth in operating revenue and a 132% year-on-year growth in adjusted EBITDA. The company reported strong profitability metrics with normalized profit after tax (PAT) growing exponentially (+3,320%) driven by operational efficiencies and integration synergies across the acquired businesses.

Capillary Technologies India Ltd reported strong revenue growth of 43% year-on-year for the quarter ended June 30, 2026, driven by healthy expansion within the existing customer base, growth in new annual contract value contributions and the addition of SessionM. Adjusted EBITDA of ₹ 440.2 Million for the quarter ended June 30, 2026 registered a year-on-year growth of 132%. Normalized Profit after tax of ₹ 254.4 Million for the quarter ended June 30, 2026 also grew exponentially (+3,320%) driven by operational efficiencies and integration synergies across the acquired businesses.

Belrise Industries Limited has informed the Exchange about Investor Presentation regarding the acquisition of India Tipper Body business from Hyva (India) Pvt.Ltd. through a Business Transfer Agreement. The acquisition is expected to strengthen Belrise's position as a Tier-0.5 supplier and add a leading European commercial vehicle OEM to its customer base. The estimated EBITDA for CY251 is ₹11.91 crores with a ROCE of 1.57 and a purchase consideration of ₹5.65 crores.

Indian Metals & Ferro Alloys Ltd reported record revenue and robust financial performance in Q1 FY27, driven by higher volumes and firm prices. The company's Greenfield Expansion Project at Kalinganagar is on track, and it has signed a long-term offtake arrangement for additional 65 MWp hybrid renewable energy.

Belrise Industries Limited has acquired the Tipper Body Business of Hyva (India) Pvt. Ltd. for approximately USD 5.65 million, strengthening its position as a Tier-0.5 supplier in the commercial vehicle ecosystem.

TruAlt Bioenergy Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with a revenue of close to INR630 crores and a PAT of close to INR4.5 crores. The company has also announced plans to increase its capacity utilization by another 20% to 25% and has secured viability gap funding of INR150 crores from the Government of India.

Belrise Industries Ltd submitted an investor presentation on the acquisition of India Tipper body business of Hyva (india) Pvt. Ltd. The acquisition is on a slump sale basis via a Business Transfer Agreement. The presentation highlights the benefits of the acquisition, including a leading European commercial vehicle OEM being added to Belrise's customer base, and the potential for increased revenue and EBITDA.

Supreme Petrochem Ltd reported Q1 FY27 earnings, with revenue from operations at INR 1693 crores, a 22% YoY growth. EBITDA stood at INR 331 crores, with a strong growth of 188% YoY, and net profit after tax was at INR 236 crores.

RITES Ltd declared 1st Interim dividend for FY 2026-27 at ₹ 1.40 per share (14% of paid-up share capital). The record date is August 10, 2026, and the dividend will be paid on or before September 2, 2026.

TruAlt Bioenergy Limited has informed the Exchange about the transcript of Earnings Conference Call held on July 29, 2026, to discuss the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.

RITES Limited has informed the Exchange that Record date for the purpose of first interim Dividend for the FY 2026-27 is 10-Aug-2026. The company has declared an interim dividend of ₹ 1.40 per share (14% of paid-up share capital) for the financial year 2026-27. The Un-Audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended on 30th June, 2026, along with Limited Review Reports thereon are enclosed herewith.

Belrise Industries Ltd has acquired the Tipper Body Business of Hyva India Private Ltd for approximately USD 5.65 million, with an EV/EBITDA multiple of 3.60x. The acquisition strengthens Belrise's position as a Tier-0.5 supplier in the commercial vehicle ecosystem and expands its capabilities in the commercial vehicle segment.

Supreme Petrochem Limited has announced its Q1 FY27 earnings, with revenue from operations at INR 1693 crores, a 22% year-on-year growth, driven by a significant increase in raw material prices due to conflict in West Asia. The company's operating EBITDA stood at INR 331 crores, with a strong growth of 188% year-on-year, and net profit after tax was at INR 236 crores.

RITES Limited has declared an interim dividend of Rs. 1.40 per equity share for the financial year 2026-27. The company has also released its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, which show a profit of Rs. 97.13 crore.

RITES Limited has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, with a profit of ₹71.80 crore and an EPS of ₹1.49. The company has also declared a 1st Interim Dividend of ₹1.40 per share (14% of paid-up share capital) for the Financial Year 2026-27.

Styrenix Performance Materials Ltd declared an interim dividend of Rs 23 per equity share for FY 2026-27, with a record date of August 10, 2026. The company also approved the unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026, along with a Limited Review Report from the Auditors.

Mankind Pharma Ltd's Q1FY27 earnings conference call transcript is available on the company's website, with overall revenue increasing to INR4,031 crores, up 13% year-on-year, and EBITDA margin improving by 250 bps year-on-year to 26.3%.